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Estrogen receptor-α (ESR1) is an important transcriptional regulator in the mammalian oviduct, however ESR1-dependent regulation of the transcriptome of this organ is not well
defined, especially at the genomic level. The objective of this study was therefore to investigate estradiol- and ESR1-dependent regulation of the transcriptome of the oviduct using
transgenic mice, both with (ESR1KO) and without (wild-type, WT) a global deletion of
ESR1. Oviducts were collected from ESR1KO and WT littermates at 23 days of age, or
ESR1KO and WT mice were treated with 5 IU PMSG to stimulate follicular development
and the production of ovarian estradiol, and the oviducts collected 48 h later. RNA extracted
from whole oviducts was hybridized to Affymetrix Genechip Mouse Genome 430–2.0 arrays
(n = 3 arrays per genotype and treatment) or reverse transcribed to cDNA for analysis of the
expression of selected mRNAs by real-time PCR. Following microarray analysis, a statistical two-way ANOVA and pairwise comparison (LSD test) revealed 2428 differentially
expressed transcripts (DEG’s, P < 0.01). Genotype affected the expression of 2215 genes,
treatment (PMSG) affected the expression of 465 genes, and genotype x treatment affected
the expression of 438 genes. With the goal of determining estradiol/ESR1-regulated function, gene ontology (GO) and bioinformatic pathway analyses were performed on DEG’s in
the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Significantly
enriched GO molecular function categories included binding and catalytic activity. Significantly enriched GO cellular component categories indicated the extracellular region. Significantly enriched GO biological process categories involved a single organism, modulation of
a measurable attribute and developmental processes. Bioinformatic analysis revealed
ESR1-regulation of the immune response within the oviduct as the primary canonical pathway. In summary, a transcriptomal profile of estradiol- and ESR1-regulated gene expression and related bioinformatic analysis is presented to increase our understanding of how
estradiol/ESR1 affects function of the oviduct, and to identify genes that may be proven as
important regulators of fertility in the future.
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Introduction
Gamete storage and maturation, fertilization, and early embryonic development occur in the
oviduct. Ovarian-derived estradiol is a known regulator of a oviductal function, modulating
contraction of its smooth musculature [1,2] and secretion by its epithelial cells [3,4], with the
transcription factors estrogen receptor-α (ESR1) and estrogen receptor-β (ESR2) both
expressed within this organ. ESR1 has been localized to ciliated and secretory epithelial cells,
stromal cells, as well as smooth muscle cells of the oviduct [5,6,7], whereas ESR2 appears to be
largely confined to ciliated epithelial cells [6]. Immunoreactivity of both receptor subtypes to
the nucleus, cytoplasm and plasma membranes [8] indicative of both genomic and non-genomic responses. Estradiol also acts as a regulator of ESR1 protein expression [5,6,7], estradiol
and ESR1 therefore acting as important transcriptional regulators where hormone bound
receptors target the estrogen responsive element (ERE) on the promoter region of their target
genes to either enhance or repress transcription [9,10].
Genome-wide reports on estradiol/ESR1-dependent regulation of oviductal function are
lacking. Our objective was therefore to identify estradiol/ESR1-dependent transcriptomal
changes in the oviduct using a mouse model that is deficient in ESR1 expression (ESR1KO),
testing the hypothesis that estradiol, acting through ESR1, affects the expression of mRNAs
within this organ. Immature mice were utilized to circumvent the reproductive phenotype
observed in ESR1KO mice observed following puberty, where females develop cystic ovaries
and dysfunction of the hypothalamic-pituitary axis due to elevated concentrations of circulating estradiol [11,12]. Immature mice (ESR1KO and WT) were left untreated, or were
treated with PMSG to stimulate follicular development and the production of estradiol.
Microarray-based transcriptional profiling and bioinformatic analyses was therefore performed using oviducts collected from mice bearing a global deletion of ESR1 and their wildtype (WT) littermates, both before and after PMSG-induced production of ovarian
estradiol.
To provide the reader with full access to the transcriptomal dataset, the raw data ( .cel files)
plus the GCRMA-normalized and log2 transformed transcript data (Park Genomics Suite
[13]), have been deposited into the Gene Expression Omnibus (National Center for Biotechnology Information [14]) as accession number GSE72614 (http://www.ncbi.nlm.nih.gov/geo).

Materials and Methods
Animals and Tissue Collection
All animal procedures were approved by the University of Kentucky Institutional Animal Care
and Use Committee. Mice with a global deletion of ESR1 (ESR1KO) on a C57BL/6 background
were generated as previously described [15,16]. Briefly, two transgenic mouse lines were used;
male ESR1flox/flox were bred with female Zp3cre to produce a line expressing Cre recombinase
in the oocyte. The F1 heterozygotes (ESR1flox/+Zp3cre) were bred with ESR1flox/flox resulting in
ESR1flox/floxZp3cre mice, where females produce oocytes that are ESR1-. ESR1flox/floxZp3cre
females were then bred with ESR1flox/- males to produce ESR1KO progeny (ESR1-/- and
ESR1-/- ZP3Cre) or sibling controls (ESR1flox/- and ESR1flox/- ZP3Cre). Genomic DNA was
extracted from ear punches using the Easy DNA kit (Invitrogen, Carlsbad CA) to confirm
genotypes, as previously described [16]. Whole oviducts were collected for extraction of RNA
from immature female mice (ESR1KO and WT) killed at 23 days of age, or ESR1KO and WT
mice treated i.p. with 5 IU PMSG at 23 days of age and killed 48 h later.
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RNA Extraction
Oviducts were pooled from 3–4 mice per treatment group and genotype and total RNA was
extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA) and purified through RNeasy columns (Qiagen, Valencia, CA), as described before [15,17]. RNA was analyzed for quality and
quantified by spectrophotometry using an Eppendorf BioPhotometer Plus (Eppendorf, Germany) as well as by visual distinction of 18S and 28S rRNA bands after ethidium bromide
staining in an agarose gel. Spectrophotometry revealed a mean 260/280 ratio of 1.75 ± 0.10 for
all samples. Aliquots of the same total RNA were used for both microarray and real-time
reverse-transcription PCR (real-time RT-PCR).

Microarray Hybridization
A total of 12 microarray hybridizations were performed using the Affymetrix Genechip Mouse
Genome 430–2.0 arrays (GeneChip; Affymetrix, Inc., Santa Clara, CA) according to the manufacturer’s instructions at the University of Kentucky Microarray Core Facility, as described
before [15,17,18]. Three replicates using different mice were generated for each treatment
group.
Microarray data were analyzed by importing raw expression intensity values ( .cel files) into
Partek Genomics Suite 6.6 (Partek Inc., St. Louis, MO), where the GC-Robust Multiarray Analysis algorithm (GC-RMA), quantile normalization, and Median Polish was applied for GeneChip background correction, log base 2 transformation, conversion of expression values and
probeset summarization. Annotation was performed using NetAffx annotation database
(Release 34) on December 3rd, 2014. Quality of data was assessed using light intensity expression values on a per chip and per gene basis and visualized as box plots (Fig 1). Principal component analysis (PCA) was conducted to determine the quality of the microarray hybridization
and visualize the general data variation among the chips (Fig 2, [13]).

Statistical, Gene Ontology and Pathway Analysis
To detect differentially expressed genes (DEG’s) and the interaction between genotype and
PMSG treatment, the normalized and background adjusted microarray data were imported
into Partek Genomics suite 6.6 (Partek, Inc.) and a two-way ANOVA performed with factor 1
being genotype and factor 2 being PMSG treatment. Statistical significance of difference for
each gene was set to P-value <0.01 with Benjamini-Hochberg multiple testing correction for
false discovery rate (FDR) < 0.13. Genes considered significant in the overall model (P < 0.01,
FDR < 0.13) were then subjected to pairwise comparisons using Fischer’s Least Significant Difference (LSD) test to estimate the significance of difference for each gene in each comparison.
Genes showing a mean difference in signal intensity of at least 2-fold change and a Pvalue < 0.01 were considered differentially expressed.
With our primary objective of identifying estradiol/ESR1-dependent affects on the transcriptome, the 1185 DEG’s identified in the oviducts of PMSG-treated ESR1KO versus PMSGtreated WT mice was subjected to gene ontology and pathway analysis. Differentially expressed
genes were interrogated for their gene ontology (GO) classes using Partek Genomics Suite 6.6
(Partek, Inc.). Partek derives gene ontology classifications from geneontology.org and/or the
affymetrix database. GO hierarchies leads to the division of the gene list into significant classifications when the observed number of differentially expressed genes in a GO category is greater
than expected. Statistical analysis for significant classifications was performed using Fischer’s
exact test, right-tailed. A P-value < 0.01 is suggestive of an over representation of genes from
within a particular GO category, indicative of a functional effect.
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Fig 1. Box plot of the log2 expression signal for each microarray chip.
doi:10.1371/journal.pone.0147685.g001

These same DEG’s (PMSG-treated ESR1KO versus PMSG-treated WT) were then subjected
to Ingenuity Pathway Analysis (IPA1, QIAGEN Redwood City, www.qiagen.com/ingenuity)
which uses multiple databases to extrapolate significant pathways based on the number of significant genes within our list and known to be involved in a particular pathway. To determine
significant pathways in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT
treated mice, a Fischer’s exact test was performed with significance set to P-value < 0.05.

Real-time RT-PCR
Pathway analysis revealed that the most significant pathways were reflective of immune
responses. Therefore, to validate the microarray analysis, real-time RT-PCR was performed to
quantify the level of expression of a selection of immune-regulating mRNAs: chemokine (C-C
motif) ligand 5, Ccl5; cytochrome P450, family 26, subfamily A, polypeptide 1, Cyp26a; hematopoetic prostaglandin D synthase, Hpgds; interleukin 18 receptor accessory protein, Il18rap;
prostaglandin-endoperoxide synthase 2, Ptgs2; lecithin retinol acyltransferase (phosphatidylcholine-retinol O-acyltransferase), Lrat; S100 calcium binding protein A8, S100a8; and uroplakin 1A, Upk1a. Real-time RT-PCR was performed using an Eppendorf Mastercycler ep
realplex2 system (Eppendorf) using iQ SYBR Green Supermix (Bio-RAD, Hercules, CA), as
described before [15,17].
Briefly, cDNA was synthesized using the SuperScript III 1st Strand Synthesis System (Invitrogen), with 0.5 μg of RNA used for each reverse transcription reaction. Real-time RT-PCR
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Fig 2. Principal component analysis (PCA) of the microarray-derived transcriptomal results for oviducts collected from ESR1KO mice and WT
littermates at 23 days of age, or treated with 5 IU PMSG at 23 days of age and collected 48 h later. Red: ESR1KO, Blue: WT, Green: PMSG-treated
ESR1KO, Purple: PMSG-treated WT.
doi:10.1371/journal.pone.0147685.g002

was performed with a total volume of 25 μl per reaction, with each reaction containing 5 μL of
cDNA, 1 μL of a 10 μM stock of each primer (forward and reverse), 12.5 μL of 2× SYBR Green
PCR Master Mix, and 5.5 μL of nuclease-free water. Gene expression was analyzed by the 2−ΔΔCT
method [19]. The typical dissociation curves of these cDNA, plus Gapdh as the housekeeping gene
was confirmed. Oligonucleotide primer pairs (Integrated DNA technologies, Coralville, IA) are
described in Table 1.
For statistical analysis of real-time RT-PCR results, datasets were first tested for normality
and equal variance. When appropriate, data were transformed before statistical analysis. A
one-way ANOVA using SigmaStat 3.5 (Systat Software, Inc., Point Richmond, CA, USA) was
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Table 1. Primer sequences (forward and reverse) and PCR product sizes used for real-time RT-PCR analyses.
Name

Accession #

Ccl5

NM_013653.3

Primer sequence (5'–3')
F: CCT CAC CAT ATG GCT CGG AC

Product size
121

R: ACG ACT GCA AGA TTG GAG CA
Cyp26a1

NM_007811.2

Hpgds

NM_019455.4

F: AGC TCC TGA TTG AGC ACT CG

292

R: GGA GGA TTC AAT CGC AGG GT
F: CAC TAG TTT CCT GGC TAG GGT

383

R: TGT CAC AGC TCC TTT CCT TGT
Il18rap

NM_010553.3

F: TGC AAT GAA GCG GCA TCT GT

133

R: CCG GTG ATT CTG TTC AGG CT
Lrat

NM_023624.4

F: GTC GCC CAT CTA ATG CCT GA

324

R: CTG TGG ACT GAT CCG AGA GC
Ptgs2

NM_011198.4

S100a8

NM_013650.2

F: CAT CCC CTT CCT GCG AAG TT

178

R: CAT GGG AGT TGG GCA GTC AT
F: CTT TCG TGA CAA TGC CGT CTG

99

R: AGA GGG CAT GGT GAT TTC CT
Upk1a

NM_026815.2

F: TGA GCA AGA GTG TTG TGG CA

240

R: CAC GAT ATG CCC CAC GTG TA
Gapdh

GU214026.1

F: CCC CCA ATG TGT CCG TCG TGG

201

R: TGA GAG CAA TGC CAG CCC CG
doi:10.1371/journal.pone.0147685.t001

used to determine differences in levels of mRNA. When differences were detected a Fischer’s
Least Significant Difference (LSD) test was used to determine which genes differed.

Results
Detection of DEG’s by Microarray Analysis
After chip normalization, a statistical two-way ANOVA and pairwise comparison (LSD test)
was performed to generate a list of 2428 differentially expressed genes (P < 0.01, FDR < 0.13).
Genotype affected the expression of 2215 genes, PMSG affected the expression of 465 genes,
and Genotype x PMSG affected the expression of 438 genes (Table 2). Following removal of
Table 2. Number of differentially expressed genes (DEG's) identified by microarray analysis and pair-wise comparisons between genotypes and
treatments.
Parameter

No. of DEG's

Model

2428

Genotype

2215

PMSG treatment

465

Genotype by PMSG interaction

438

Pairwise comparisons

No. of DEG's

Up-regulated

PMSG-treated ESR1KO vs. ESR1KO

37

31 (84%)

6 (16%)

PMSG-treated WT vs. WT

318

164 (52%)

154 (48%)

PMSG-treated ESR1KO vs. PMSG-treated WT

1185

689 (58%)

496 (42%)

ESR1KO vs. WT

664

328 (49%)

336 (51%)

Down-regulated

Signiﬁcance set to P-value < 0.01 with FDR determined from the Benjamini-Hochberg multiple testing correction < 0.13. For pairwise comparisons,
unannotated and duplicate probe sets were removed from gene lists, and only genes with at least a 2-fold change in level of expression were considered
differentially expressed.
doi:10.1371/journal.pone.0147685.t002
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Table 3. Top 20 most highly up-regulated mRNAs in the oviducts of ESR1KO versus WT mice. Overall Model: P < 0.01 and at least a 2-fold change in
gene expression.
Gene Symbol

Gene Description

P-value

Fold-Change

Sult1e1

sulfotransferase family 1E, member 1

< 0.001

33.1834

Chodl

chondrolectin

< 0.001

25.6824

Avpr1a

arginine vasopressin receptor 1A

< 0.001

24.7639

Synpr

synaptoporin

< 0.001

22.5126

Glb1l3

galactosidase, beta 1 like 3

< 0.001

21.5821

BC048679

cDNA sequence BC048679

< 0.001

21.0171

Ager

advanced glycosylation end product-speciﬁc receptor

< 0.001

17.8374

2310043J07Rik

RIKEN cDNA 2310043J07 gene

< 0.001

15.0383

Pcdh8

protocadherin 8

< 0.001

14.7291

Lemd1

LEM domain containing 1

< 0.001

14.6033

Slc47a1

solute carrier family 47, member 1

< 0.001

14.215

Adamts16

a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 mo

< 0.001

13.9153

Tnfrsf21

tumor necrosis factor receptor superfamily, member 21

< 0.001

12.0567

9330159F19Rik

RIKEN cDNA 9330159F19 gene

< 0.001

11.991

S100a8

S100 calcium binding protein A8 (calgranulin A)

0.002

11.9115

Mmp7

matrix metallopeptidase 7

< 0.001

11.8858

Kcnd2

potassium voltage-gated channel, Shal-related family, member 2

< 0.001

11.8108

AA986860

expressed sequence AA986860

< 0.001

11.5917

Cdh16

cadherin 16

< 0.001

11.5566

Trank1

tetratricopeptide repeat and ankyrin repeat containing 1

< 0.001

11.4235

Fold-Change in gene expression and P-Values are indicated. Positive changes in fold-change represent increased expression in the oviducts of ESR1KO
mice.
doi:10.1371/journal.pone.0147685.t003

unannotated and duplicate probesets, DEG’s were further subdivided between up- and downregulated genes. The identity of the 20 most highly up- and down-regulated genes in the oviducts of ESR1KO versus WT mice, and PMSG-treated ESR1KO versus PMSG-treated WT
mice are provided in Tables 3–6. The identity of all genes determined to be differentially
expressed by two-way ANOVA is provided in S1 Table.

Verification of selected DEG’s
The expression of mRNA for Ccl5, Cyp26a1, Hpgds, Il18rap, Lrat, Ptgs2, S100a8, and Upk1a in
the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice was determined by
real-time RT-PCR. A comparison of the results obtained by real-time RT-PCR and microarray
analysis is presented in Table 7 as a validation of the microarray platform. Overall, real-time
RT-PCR revealed the same directional trends in gene expression that were observed by the
microarray analysis.

Gene Ontology Analysis of DEG’s in the oviducts of PMSG-treated
ESR1KO versus PMSG-treated WT mice
Consistent with our overall goal of identifying estradiol/ESR1-dependent affects on the oviduct, the molecular functions, cellular components, and biological processes of DEG’s
expressed in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice were
determined by Gene Ontology (GO) Analyses with significance set to enrichment Pvalue < 0.01. The significantly enriched molecular function categories using GO are shown in

PLOS ONE | DOI:10.1371/journal.pone.0147685 January 25, 2016
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Table 4. Top 20 most highly down-regulated mRNAs in the oviducts of ESR1KO versus WT mice. Overall Model: P < 0.01 and at least a 2-fold change
in gene expression.
Gene Symbol

Gene Description

Pcdh17

protocadherin 17

Csf3

colony stimulating factor 3 (granulocyte)

Tshr

Pvalue

FoldChange

< 0.001

-10.6901

0.002

-11.5917

thyroid stimulating hormone receptor

< 0.001

-11.8455

Col6a4

collagen, type VI, alpha 4

< 0.001

-12.206

Akr1c14

aldo-keto reductase family 1, member C14

< 0.001

-12.2614

Upk1a

uroplakin 1A

0.001

-12.9078

Slc6a2

solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2

< 0.001

-13.1394

Lrat

lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)

< 0.001

-13.3562

Ano4

anoctamin 4

0.002

-13.6892

Gp1bb

glycoprotein Ib, beta polypeptide

< 0.001

-15.0412

Stat5a

signal transducer and activator of transcription 5A

< 0.001

-16.1053

Rtn1

reticulon 1

< 0.001

-18.0311

Syn2

synapsin II

< 0.001

-23.8067

Ramp3

receptor (calcitonin) activity modifying protein 3

< 0.001

-24.6301

Mlc1

megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human)

< 0.001

-29.3425

Hpgds

hematopoietic prostaglandin D synthase

0.001

-32.2313

Cyp26a1

cytochrome P450, family 26, subfamily a, polypeptide 1

0.001

-39.5376

Dcpp1 /// Dcpp2 ///
Dcpp3

demilune cell and parotid protein 1 /// demilune cell and parotid protein 2 /// demilune cell and
parotid protein 3

< 0.001

-47.7492

2300002M23Rik

RIKEN cDNA 2300002M23 gene

Dcpp3

demilune cell and parotid protein 3

0.003

-71.6374

< 0.001

-77.6391

Fold-Change in gene expression and P-Values are indicated. Negative changes in fold-change represent decreased expression in the oviducts of
ESR1KO mice.
doi:10.1371/journal.pone.0147685.t004

Fig 3A. The categories with the highest enrichment score within molecular functions were
binding, catalytic and transporter activities. Significantly enriched cellular component categories are shown in Fig 3B. The most highly enriched cellular component categories were the
extracellular region/matrix and the cell membrane. Significantly enriched biological processes
are indicated in Fig 3C, with the most highly enriched categories including those involving a
single organism, modulating a measurable attribute (biological regulation) and specific outcome (developmental process).

Ingenuity Pathway Analysis of DEG’s in the oviducts of PMSG-treated
ESR1KO versus PMSG-treated WT mice
Canonical pathway analysis of DEG’s from PMSG-treated ESR1KO versus PMSG-treated WT
mice was performed using QIAGEN’S Ingenuity Pathway Analysis (IPA, QIAGEN, Redwood
City, www.qiagen.com/ingenuity). The six most significant pathways identified by Ingenuity
Pathway Analysis software are provided in Fig 4, and are reflective of ESR1-dependent regulation of the immune response. The top upstream regulators were tumor necrosis factor (TNF),
interferon gamma (IFNG), interleukin 1β (IL1B), amyloid β (A4) precursor protein (APP) and
interleukin 13 (IL13). The top regulator effect networks included a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 (ADAMTS12), homeodomain interacting protein kinase 2 (HIPK2), interleukin 22 (IL22), interleukin 27 (IL27), toll-like receptor
3 (TLR3), toll-like receptor 4 (TLR4) and conserved helix-loop-helix ubiquitous kinase

PLOS ONE | DOI:10.1371/journal.pone.0147685 January 25, 2016
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Table 5. Top 20 most highly up-regulated mRNAs in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Overall Model: P < 0.01
and at least a 2 fold-change in gene expression.
Gene Symbol

Gene Description

P-value

Fold-Change

BC048679

cDNA sequence BC048679

<0.001

222.15

Apod

apolipoprotein D

<0.001

98.02

Cdh16

cadherin 16

<0.001

50.13

Chodl

Chondrolectin

<0.001

48.14

Sult1e1

sulfotransferase family 1E, member 1

<0.001

46.32

G6pc2

glucose-6-phosphatase, catalytic, 2

<0.001

42.88

Pla2g10

phospholipase A2, group X

<0.001

40.8

Fgf18

ﬁbroblast growth factor 18

<0.001

38.17

Avpr1a

arginine vasopressin receptor 1A

<0.001

35.78

Aldh1a3

aldehyde dehydrogenase family 1, subfamily A3

<0.001

34.76

Lrrtm1

leucine rich repeat transmembrane neuronal 1

<0.001

29.44

Serpina1b

serine (or cysteine) preptidase inhibitor, clade A, member 1B

<0.001

27.57

Ager

advanced glycosylation end product-speciﬁc receptor

<0.001

22.77

Synpr

Synaptoporin

<0.001

22.32

S100a8

S100 calcium binding protein A8 (calgranulin A)

<0.001

20.77

Adamts16

a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif 16

<0.001

19.82

Il18r1

interleukin 18 receptor 1

<0.001

19.45

S100a9

S100 calcium binding protein A9 (calgranulin B)

0.0015

17.86

Atp6v1b1

ATPase, H+ transporting, lysosomal V1 subunit B1

<0.001

17.8

Wnt7a

wingless-related MMTV integration site 7A

<0.001

17.49

Fold-Change in gene expression and P-Values are indicated. Positive changes in fold-change represent increased expression in the oviducts of PMSGtreated ESR1KO mice.
doi:10.1371/journal.pone.0147685.t005

(CHUK) as their primary regulators. With pathway analysis indicating the immune response
as a primary canonical pathway, a listing of differentially expressed mRNAs specifically encoding chemokines, interleukins and their receptors in the oviducts of PMSG-treated ESR1KO
versus PMSG-treated WT mice is provided as Table 8. All the significant pathways (Pvalue < 0.05) and the corresponding molecules differentially expressed within the pathways
from PMSG-treated ESR1KO versus PMSG-treated WT mice are provided in S2 Table.

Discussion
The objective of this study was to determine estradiol/ESR1-dependent changes to the transcriptome of the mouse oviduct, with the overall goals of increasing our understanding of steroidal regulation of this often overlooked reproductive organ, and to provide the identity of
ESR1-regulated genes that may prove to be important modulators of oviductal function and
fertility in the future. While our focus was on the identification and bioinformatic analysis of
DEG’s in the oviducts of PMSG-treated WT versus PMSG-treated ESR1KO mice, the identity
of all DEG’s identified by this analysis have been provided (S1 Table), and the raw data ( .cel
files) plus the GC-RMA-normalized and log2 transformed transcript data have been deposited
into the Gene Expression Omnibus. Important to note, whole oviducts were collected for transcriptomal analysis from WT and ESR1KO mice. Future research of targeted mRNAs identified
by this analysis will therefore need to include determination of potential differences in spatial
location of a gene or protein between the ampulla and isthmus, as well as cellular localization
within a specific section of the oviduct. Furthermore, this study was performed to determine
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Table 6. Top 20 most highly down-regulated mRNAs in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Overall Model:
P < 0.01 and at least a 2 fold-change in gene expression.
Gene Symbol

Gene Description

P-value

Fold-Change

Dcpp3

demilune cell and parotid protein 3

<0.001

-770.92

2300002M23Rik

RIKEN cDNA 2300002M23 gene

<0.001

-524.94

Cyp26a1

cytochrome P450, family 26, subfamily a, polypeptide 1

<0.001

-131.13

Tshr

thyroid stimulating hormone receptor

<0.001

-121.71

Dcpp1/2/3

demilune cell and parotid protein 1/demilune cell and parotid protein 2/demilune cell and parotid protein 3

<0.001

-106.94

Syn2

synapsin II

<0.001

-91.45

Slc6a2

solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2

<0.001

-77.2

Upk1a

uroplakin 1A

<0.001

-77.14

Hpgds

hematopoietic prostaglandin D synthase

<0.001

-73.37

Klk1b24

kallikrein 1-related peptidase b24

<0.001

-73.19

Greb1

gene regulated by estrogen in breast cancer protein

<0.001

-64.6

Klk1b1

kallikrein 1-related peptidase b1

<0.001

-62.94

Klk1b21

kallikrein 1-related peptidase b21

<0.001

-53.58

Lrat

lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)

<0.001

-53.53

Gria1

glutamate receptor, ionotropic, AMPA1 (alpha 1)

<0.001

-46.45

Akr1c14

aldo-keto reductase family 1, member C14

<0.001

-45.65

Stat5a

signal transducer and activator of transcription 5A

<0.001

-44.22

Col6a4

collagen, type VI, alpha 4

<0.001

-43.1

Rasd1

RAS, dexamethasone-induced 1

<0.001

-42.74

Adh7

alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide

<0.001

-42.46

Fold-Change in gene expression and P-Values are indicated. Negative changes in fold-change represent decreased expression in the oviducts of PMSGtreated ESR1KO mice.
doi:10.1371/journal.pone.0147685.t006

estradiol/ESR1-dependent regulation; genomic signaling via ESR2 and non-genomic effects of
estradiol on the oviduct via activation of G-protein-coupled receptor 30 (GPR30, [20]) should
not be overlooked, nor potential interactions. Indeed, regardless of treatment with PMSG, we
observed that ablation of ESR1 resulted in a 1.6-fold increase in the expression of mRNA for
Gpr30 in the oviduct (S1 Table).
Table 7. Comparison of gene expression for selected mRNAs by microarray and real-time RT-PCR in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice.
Microarray
Gene Symbol

Fold-Change

Real-time RT-PCR
P-Value

Fold-Change

P-Value

2

0.166

4.2

< 0.001

Cyp26a1

-131.1

< 0.001

-27.4

< 0.001

Hpgds

-73.4

< 0.001

-13.4

< 0.001

Il18rap

1

0.22

6.2

< 0.001

Lrat

-53.5

< 0.001

-21.8

< 0.001

Ptgs2

1.57

0.24

2.19

< 0.001

S100a8

20.7

0.0006

18.02

< 0.001

Upk1a

-77.1

< 0.001

-38.9

< 0.001

Ccl5

Fold-Change in gene expression and P-Values are indicated after analysis by microarray and by independent real-time RT-PCR. Positive changes in fold
change represent increased expression in the oviducts of PMSG-treated ESR1KO mice.
doi:10.1371/journal.pone.0147685.t007
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Fig 3. Gene Ontology (GO) analysis with Molecular Function, Cellular Component and Biological Processes categories. Pie chart shows the
distribution of the DEG’s in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice that were matched to A) a Molecular Function, B) a
Cellular Component, and C) a Biological Process, using GO.
doi:10.1371/journal.pone.0147685.g003
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Fig 4. Most highly significant canonical pathways identified in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT identified using
QIAGEN’S Ingenuity Pathway Analysis.
doi:10.1371/journal.pone.0147685.g004

ESR1-dependent regulation of immune function was a leading canonical pathway identified.
Of note, inflammation and the immune response is a required physiological occurrence within
the oviduct as this organ is exposed to freshly ovulated cumulus-oocyte complexes, associated follicular debris, spermatozoa, seminal fluids and possibly an array of foreign pathogens at ovulation and/or mating [21,22,23,24]. However, salpingitis or aberrant inflammation is also one of
the most common forms of pelvic inflammatory disease (PID) and is one of the most important
components of the PID spectrum due to its impact on female fertility (reviewed in [25]). This
uncontrolled inflammation results in oviductal epithelial cell death, tubal scarring and eventually
occlusion [26,27,28,29,30], making identification of the specific transcripts involved in ESR1-dependent regulation of immune function a salient finding of this transcriptomal analysis.
Overall, with significance set to P < 0.01, greater than two thousand transcripts were determined to be differentially regulated. A pairwise comparison of DEG’s in 23 day old ESR1KO
and WT mice (i.e. without PMSG-stimulated production of ovarian estradiol) revealed 664
DEG’s, and a pairwise comparison of DEG’s in PMSG-treated WT versus PMSG-treated
ESR1KO oviducts revealed 1185 differentially regulated genes, which were subsequently analyzed for gene ontology as well as with Ingenuity Pathway Analysis (IPA1, QIAGEN), which
uses multiple databases to extrapolate significant canonical pathways based on the number of
genes expected to be expressed within each pathway. With the exception of axonal guidance
signaling (reviewed in [31]), the other top canonical pathways (Fig 4) were all directly related
to immune function, as were the 5 top upstream regulators (TNF, IFNG, IL1B, APP and IL13).
We have previously reported that the expression of the hematopoetic form of prostaglandin
D synthase (HPGDS), a putative regulator of inflammation in the oviduct, is dependent upon
ESR1 [15]. In that study, genetic deletion of ESR1 reduced the expression of mRNA encoding
Hpgds and inhibition of HPGDS in wild-type mice by treatment with HQL-79 (Cayman
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Table 8. Differentially expressed mRNAs encoding chemokines, interleukins and their receptors in
the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice. Overall Model: P < 0.01 and at
least a 2-fold change in gene expression.
Gene Symbol

Gene Description

P-value

Fold-Change

Cx3cl1
Cxcl12

chemokine (C-X3-C motif) ligand 1

0.004

2.25

chemokine (C-X-C motif) ligand 12

< 0.001

4.21

Cxcl14

chemokine (C-X-C motif) ligand 14

0.001

-3.31

Cxcl16

chemokine (C-X-C motif) ligand 16

0.011

1.73

Cxcl17

chemokine (C-X-C motif) ligand 17

0.003

3.68

Cxcr4

chemokine (C-X-C motif) receptor 4

0.063

1.61

Cxcr7

chemokine (C-X-C motif) receptor 7

< 0.001

-3.32

Il13ra2

interleukin 13 receptor, alpha 2

0.003

4.48

Il15

interleukin 15

< 0.001

2.70

Il15ra

interleukin 15 receptor, alpha chain

< 0.001

5.16

Il16

interleukin 16

0.002

1.62

Il17ra

interleukin 17 receptor A

< 0.001

-2.25

Il17rb

interleukin 17 receptor B

< 0.001

14.38

Il17re

interleukin 17 receptor E

0.002

3.00

Il18

interleukin 18

0.002

1.82

Il18bp

interleukin 18 binding protein

< 0.001

-20.01

Il18r1

interleukin 18 receptor 1

< 0.001

19.45

Il1r1

interleukin 1 receptor, type I

0.001

2.14

Il1rap

interleukin 1 receptor accessory protein

< 0.001

1.53

Il33

interleukin 33

< 0.001

11.69

Il7

interleukin 7

0.001

3.94

Ilf2

interleukin enhancer binding factor 2

0.012

1.31

Fold-Change in gene expression and P-Values are indicated. Positive changes in fold-change represent
increased expression in the oviducts of PMSG-treated ESR1KO mice.
doi:10.1371/journal.pone.0147685.t008

Chemical, Ann Arbor, MI) resulted in a 2.3-fold increase in the expression of mRNA for one of
the upstream regulators identified herein (IL13), a 2.9-fold increase in the expression of mRNA for
chemokine (C-X-C motif) ligand 12 (Cxcl12), as well as a 1.8-fold increase in the expression of
mRNA for TNF receptor superfamily, member 1b (Tnfrsf1b) which is also known as TNF receptor
2 (TNFR2), one of the two receptors that bind TNFα. Herein, the expression of mRNA for Cxcl12
and Tnfrsf1b was 4.2- and 2.5-fold higher in the oviducts of PMSG-treated ESR1KO versus
PMSG-treated WT mice (Table 8 and S1 Table). Taken together, our results are consistent with
regulation of inflammation within the oviduct acting, in part, through ESR1-dependent HPGDS
signaling. Of physiological relevance, the expression of TNFα is reported to increase after infection
of human oviducts with Neisseria gonorrhoeae in vitro [32] and genetic deletion of IL13 in mice
improves the rate of clearance after genital infection with Chlamydia muridarum [33], two bacterial pathogens known to induce an inflammatory response within the oviduct [34,35]. Interestingly, the expression of mRNA encoding IL13 receptor, alpha 2 (Il13ra2), but not Il13, was
increased in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice (Table 8).
Of the mRNAs selected for independent analysis by real-time RT-PCR, directional trends
were consistent among microarray and RT-PCR analyses (Table 7). Analysis by real-time
RT-PCR also revealed that the expression of Ptgs2 and Il18rap was increased in the oviducts of
PMSG-treated ESR1KO versus PMSG-treated WT mice. Importantly, for these two transcripts,
microarray analysis revealed the same directional trend and a similar magnitude or fold-
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change in expression. Estradiol is a known regulator of PTGS2 in the oviduct [36], and
IL18RAP together with the receptor IL18R1 (interleukin 18 receptor 1) mediates IL18-dependent activation [37,38]. IL18 is a Caspase-1-dependent inflammatory cytokine induced by
infection with C. trachomatis [39]. We observed a 19-fold increase in the expression of Il18r1
in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice (Tables 5–8), which
is also consistent with the regulation of the IL18 receptor by estradiol, as reported in the uterine
endometrium [40]. Among the other DEG’s encoding interleukins, mRNA encoding IL17
receptors A, B and E (Il17ra, Il17rb and Il17re) as well as interleukin 1 receptor, type 1 (Il1r1)
and interleukin 1 receptor accessory protein (Il1rap) differed in the oviducts of PMSG-treated
ESR1KO versus PMSG-treated WT mice (Table 8). Mice deficient in IL17 display an attenuated response to genital infection with C. muridarium [41], whereas IL1 is an established regulator of C. trachomatis-induced inflammation in the oviduct [42]. Our results therefore
revealing estradiol/ESR1-dependent changes within the oviduct of transcripts reported to affect
inflammation in response to targeted bacterial challenges by others.
Differences in the magnitude of change were observed for some transcripts by microarray
analysis versus real-time RT-PCR, as expected [43], whereas technique did not affect the magnitude of change for others. For example, microarray analysis revealed that the S100 calcium
binding proteins A8 and A9 were increased by 21-and 18-fold, respectively, in PMSG-treated
ESR1KO versus PMSG-treated WT oviducts (Table 5). Real-time RT-PCR confirmed the
increased expression of S100A8, with the relative expression for this mRNA increased by
18-fold in the PMSG-treated ESR1KO oviduct (Table 7). The S100 calcium binding proteins
are pro-inflammatory, inducing chemotaxis and adhesion of neutrophils [44] and increasing
IL1β secretion by IFNG-primed monocytes [45]. Again, consistency with targeted bacterial
studies is observed; IL1 signaling and IL1β secretion are involved in the response of the oviduct
to infection with C. muridarium [46].
To conclude, this transcriptomal analysis can provide us with great insight into estradiol/
ESR1-dependent regulation of oviductal gene expression and presumably function. Pathway
analysis illustrated the complex role of estradiol and ESR1 in regulating oviductal function and
identified putative ESR1-dependent molecules involved. This dataset can now be examined in
greater detail by others with the hope of expanding our understanding of ESR1-dependent regulation of physiological function in this key reproductive organ.

Supporting Information
S1 Table. Listing of the 2428 differentially expressed genes (P < 0.01, FDR < 0.13) identified by two-way ANOVA and pairwise comparison (LSD test). Gene symbol, gene title and
all pair-wise comparisons, P-values and fold changes in expression are indicated.
(XLS)
S2 Table. Complete results of the canonical pathway analysis of DEG’s from PMSG-treated
ESR1KO versus PMSG-treated WT mice, performed using QIAGEN’S Ingenuity Pathway
Analysis (IPA, QIAGEN, Redwood City, www.qiagen.com/ingenuity). All the significant
pathways (P-value  0.05) and the corresponding molecules differentially expressed within the
pathways from PMSG-treated ESR1KO versus PMSG-treated WT mice are indicated.
(XLS)
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